loader image
Friday, November 28, 2025
71.2 F
McAllen
- Advertisement -

Study Finds Best Strategy for Reducing Belly Fat

Translate to Spanish or other 102 languages!

Over the last few years, research has shown that having excessive visceral fat — the fat surrounding the abdominal area that protects internal organs — can be detrimental to a person’s health. Image for illustration purposes
Over the last few years, research has shown that having excessive visceral fat — the fat surrounding the abdominal area that protects internal organs — can be detrimental to a person’s health. Image for illustration purposes
- Advertisement -

Medical News Today

Over the last few years, research has shown that having excessive visceral fat — the fat surrounding the abdominal area that protects internal organs — can be detrimental to a person’s health.

Past studies show that having an unhealthy amount of visceral fat may increase a person’s risk for several health conditions, including type 2 diabetesmetabolic syndromenonalcoholic fatty liver diseaseTrusted Sourcecardiovascular diseasestrokesleep apneacancerTrusted Source, and Alzheimer’s diseaseTrusted Source.

- Advertisement -

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/diet-exercise-study-best-strategy-reducing-belly-fat-weight-loss?utm_term=feature&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-11-28&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

AMA Adopts New Public Health Policies to Improve Health of the Nation

The American Medical Association (AMA) gathered physician and medical student leaders from all corners of medicine at its Interim Meeting of the House of Delegates to shape guiding policies on emerging health care topics.

FDA Approves Gene Therapy for Treatment of Spinal Muscular Atrophy

The U.S. Food and Drug Administration approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spinal muscular atrophy (SMA) in adult and pediatric patients 2 years of age and older with confirmed mutation in the survival motor neuron 1 (SMN1) gene. Itvisma is an adeno-associated virus (AAV) vector-based gene therapy.

Can Your Driving Patterns Predict Cognitive Decline?

Using in-vehicle driving data may be a new way to identify people who are at risk of cognitive decline, according to a study published on November 26, 2025, in Neurology®, the medical journal of the American Academy of Neurology.

Educating Older Adults On Age-Related Weight Gain, Dec. 5th

The “Living with Weight Gain” program is part of STHS & Prominence Health’s “Senior Living Seminar Series,” which focuses on providing essential education on common health issues affecting the elderly population
- Advertisement -
×